You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Swiss diagnostic firm Calciscon announced Thursday it has closed a $650,000 pre-series A financing round and will prepare for series A financing.
After this round, the total equity investment in Calciscon is $2.7 million.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.